Rotavirus-specific cytotoxic T lymphocytes (CTL) play an important role in the resolution of rotavirus infection. The outer capsid glycoprotein, VP7, elicits a class I MHC-restricted CTL response. Vaccinia virus recombinants expressing the VP7 genes from simian rotavirus SA11 (serotype G3) and from the RF strain of bovine rotavirus ( Splenocytes obtained from rotavirus SA11-infected C57BL/6 mice induced the strongest CTL response against target cells sensitized with a peptide containing a K b -restricted CTL epitope (amino acids 8-16). A second K d -restricted epitope (residues 5-13) was recognized by splenocytes derived from rotavirus-infected BALB/c mice. These findings reveal the existence of CTL epitopes in the H1 signal sequence of the VP7 glycoprotein that coexist with a CTL epitope (residues 31-40) previously described within the H2 region.
INTRODUCTION
Group A rotaviruses are one of the leading causes of viral gastroenteritis in infants and young children (Kapikian and Chanock, 1996) . Infected subjects may be protected against subsequent infection and this protection reduces the severity of the diarrhea (Coulson et al., 1992; Velá zquez et al., 1996) . Despite extensive research on rotavirus, the precise nature of the immunological effector mechanisms involved in protection against rotavirus disease are only partly understood (Midthun and Kapikian, 1996; Ward, 1996) and such knowledge is needed in order to design an efficient vaccine strategy. An oral rotavirus vaccine was recently approved since the results obtained in clinical trials proved that it induces a significant reduction in severe diarrhea caused by rotavirus Pé rez-Schael et al., 1997) .
Cytotoxic T lymphocytes (CTL) are thought to be important in controlling primary rotavirus infections and in the immune protection against reinfections (Offit and Dudzik, 1988; Franco et al., 1997; Heath et al., 1997) . Although antibodies, mainly rotavirus-specific intestinal IgA, seem to be important determinants of protection against rotavirus reinfection in mice (McNeal et al., 1995; Franco and Greenberg, 1995; Moser et al., 1998) and in humans (Matson et al., 1993; Ward and Bernstein, 1995; Colomina et al., 1998) , a role for CD8 ϩ T cells in protection from viral reinfection has also been recognized (McNeal et al., 1995; Franco et al., 1997) . There are data from experimental rotavirus infections in mice that support the hypothesis that rotavirus-specific CTL may protect against disease. Rotavirus-specific CTL are detected at the intestinal mucosal surface in mice within the first week of infection (Offit and Dudzik, 1989) . CD8 ϩ T cells from rotavirus-immunized adult mice passively protect suckling mice against rotavirus gastroenteritis in the absence of rotavirus-specific neutralizing antibodies (Offit and Dudzik, 1990) and mediate the clearance of chronic rotavirus infection in SCID mice (Dharakul et al., 1990) . To better characterize the effector mechanisms involved in the clearance and prevention of rotavirus infection, Franco and Greenberg (1995) studied rotavirus infections in gene knockout transgenic mice devoid of both T and B cells (Rag-2 gene knockout mice), CTL (␤ 2 -microglobulin knockout mice), and B cells (J H D knockout mice). Animals depleted of CD8 ϩ T cells have a delay in clearance of rotavirus infection and, in the absence of B cells, they become chronically infected with murine rotavirus. It has also been reported that CD8 ϩ cells are involved in the resolution of the initial infection in two B-cell-deficient mouse strains (J H D and MT mice) inoculated with the murine rotavirus strain EDIM (McNeal et al., 1995) . Furthermore, it has been shown experimentally that CD8 ϩ T cells can mediate almost complete short-term and partial long-term protection from reinfection in mice (Franco et al., 1997) . Several studies have demonstrated that the rotaviral VP7 glycoprotein induces a vigorous specific CTL response (Offit et al., 1991a (Offit et al., , 1994 Heath et al., 1997) . By inoculating mice orally with recombinant vaccinia viruses (rVV) expressing individual rotavirus genes, Offit et al. (1994) found that the greatest frequencies of virusspecific CTL were induced by recombinants expressing VP7. These rotavirus-specific CTL recognized different virus VP7 (G) serotypes and were induced in both intestinal and nonintestinal lymphocytes after oral inoculation. Similar results were obtained by Heath et al. (1997) , who used vaccinia virus recombinants expressing VP7 genes from seven G serotypes in cytotoxicity assays and found that the CTL response to VP7 is completely cross-reactive.
To gain a better understanding of the CTL response against the rotaviral VP7 glycoprotein we have carried out cytotoxicity assays using vaccinia virus recombinants expressing the VP7 molecule from both the SA11 strain of simian rotavirus (serotype G3) (VV-VP7-SA11) and the RF strain of bovine rotavirus (serotype G6) (VV-VP7-RF) and a vaccinia virus expressing a carboxy-terminally truncated VP7 protein comprising the first 88 amino acids of the SA11 protein (VV-VP7-5Ј). Synthetic peptides encompassing K b , D b , and K d allele-specific motifs were then used in CTL assays in order to determine the VP7 epitopes recognized by CTL.
RESULTS

Expression of rotavirus VP7 by recombinant vaccinia viruses
Recombinant vaccinia viruses were produced to express (i) full-length VP7 from rotavirus strain SA11 (VV-VP7-SA11), (ii) a carboxy-terminally truncated molecule comprising the first 88 amino acids of the SA11 VP7 protein (VV-VP7-5Ј), and (iii) ␤-galactosidase encoded by the Escherichia coli lacZ gene from the transfer plasmid pSC11 (VV-sc11). These recombinant viruses were analyzed by polymerase chain reaction (PCR), Southern blot hybridization, and sequence analysis and the inserts were found to be in the correct orientation. VP7 expression by recombinant vaccinia viruses was assessed by indirect immunofluorescence, Western blotting, and radioimmunoprecipitation assay (RIPA). Recombinant vaccinia virus-infected CV-1 cells were identified after staining with a hyperimmune bovine anti-rotavirus serum or with monoclonal antibodies against VP7. The reaction was localized as fluorescent patches in the perinuclear region (Fig. 1B) , which could correspond to the ER localization of VP7. It is well known that VP7 behaves as an integral membrane protein and that it is acquired by the virus during the budding process through the ER.
The expression of VP7 by both VV-VP7-SA11 and VV-VP7-RF was demonstrated by Western blot analysis using a hyperimmune goat anti-rotavirus serum ( Fig. 2A) . As no positive reaction was observed by immunofluoresence or immunoblotting of cells infected with VV-VP7-5Ј, neither with polyclonal antisera nor with monoclonal antibodies to VP7, immunoprecipitation of labeled proteins was used as the detection method (Fig. 2B) . The results obtained by RIP assay using human polyclonal anti-rotavirus and mouse monoclonal antibodies to VP7 showed that both vaccinia virus recombinants VV-VP7-SA11 and VV-VP7-RF were expressing full-length VP7, whereas a polypeptide of approximately 9 kDa was precipitated from cells infected with VV-VP7-5Ј. This molecule corresponded to the truncated VP7 protein encoded by the 5Ј fragment of gene 9 cloned into the vaccinia virus. The expression of VP7 by VV-VP7-RF and VV-VP7-SA11 was also analyzed by immunofluorescence in those cells to be used as targets in CTL assays, namely MC57, Balb Cl.7, and P815 infected with the rVV. Immunostaining with MAbs against VP7 was found to be of similar intensity with both viruses (results not shown).
Challenge of BALB/c and C57BL/6 newborn mice with homologous and heterologous rotaviruses Different percentages of suckling mice inoculated orally with SA11, EDIM, or Wa rotavirus strains suffered diarrhea for 2-5 days postinoculation at the doses given. Taking both BALB/c and C57BL/6 mouse strains together, 88% of mice challenged with SA11, 80% of mice inoculated with EDIM, and 30% of those mice infected with Wa developed transient diarrheal disease. Sera samples obtained from those animals that developed diarrhea were tested by ELISA for anti-rotavirus antibodies and in all the sera examined titers of rotavirusspecific IgG higher than 1/500 were found, demonstrating that the animals had been immunized to the viral antigens (results not shown). Splenocytes to be used in CTL assays against rotaviral antigens were obtained from those animals that developed disease after viral inoculation and were found to be rotavirus-specific IgG positive. 
CTL responses in mice immunized with EDIM rotavirus
Effector cells derived from both BALB/c and C57BL/6 mice challenged with the homologous EDIM strain elicited significant specific lysis of appropriate target cells infected with SA11 rotavirus, with recombinant vaccinia viruses carrying full-length VP7 (VV-VP7-SA11 and VV-VP7-RF), and with rVV expressing the amino terminus of the protein (VV-VP7-5Ј) (Fig. 4) . No significant differences (P ϭ 0.05) were detected in the lysis values elicited by CTL induced in both strains of mice infected and primed with homologous (EDIM) or heterologous (SA11 and Wa) rotaviruses against target cells infected with rotavirus SA11. However, effector cells derived from EDIM-infected H-2 d mice elicited a significantly lower CTL response against SA11-infected target cells than effector cells from H-2 b mice (P Ͻ 0.001).
CTL responses to target cells sensitized with peptides
To identify new CTL epitopes, synthetic peptides were designed according to the motifs described by Falk et al. (1991) (Table 1) . Table 2 shows the results of the CTL assays performed with splenocytes from mice infected with different rotavirus strains and stimulated in vitro with peptides against target cells sensitized with the appropriate peptide at 10 Ϫ6 M. Peptide Kb8-16 (amino acids 8-16) elicited the strongest specific lysis of MC57 cells mediated by effectors derived from C57BL/6 mice immunized with SA11. The lysis of MHC-matched target cells sensitized with peptides Kd5-13 (amino acids 5-13) and Kb31-40 (amino acids 31-40) at 10 Ϫ6 M was also observed and showed lysis values at least two times higher than the lysis values of control target cells (mock-infected and/or VVsc11-infected cells) ( Table 2 ). Peptide Kb2-10 was not recognized by effector cells derived from C57BL/6 mice infected with either SA11 or Wa rotavirus strains, nor was peptide Db48-57, which encompasses a potential CTL epitope in the context of H-2D b , recognized. Peptides were found to be nontoxic to target cells since the 51 Cr spontaneous release of cells incubated with each peptide was not greater than the spontaneous release without peptides.
CTL responses to target cells sensitized with peptides Kb8-16, Kb31-40, and Kd5-13 at different peptide concentrations, ranging from 10 Ϫ5 to 10 Ϫ12 M, confirmed the ability of CTL to detect the epitope defined by each peptide and to generate an efficient cell lysis (Figs. 5 and 6).
To confirm these results, splenocytes derived from C57BL/6 or BALB/c mice primed in vivo with either SA11 or EDIM virus were restimulated in vitro with the same infecting viral strain. The cytotoxic capacity of these cells was then assayed against syngeneic target cells labeled with 51 Cr and sensitized with peptides Kb8-16, Kb31-40, or Kd5-13. The results are shown in Table 3 and corroborate the identification of these epitopes by splenocytes from mice primed with two different rotavirus strains. Only peptide Kb8-16 was not recognized by effector cells from EDIM-infected C57BL/6 mice.
DISCUSSION
The effector functions responsible for clearance of rotavirus from the intestinal mucosa have been partially characterized (McNeal et al., 1995; Offit, 1996) . T cells are turning out to have an important role as frontline sentinels in the intestinal mucosa against viral infections. The precise function of the CTL response in rotavirus immunity has been the focus of numerous studies (Offit et al., 1991b; Franco and Greenberg, 1995; Heath et al., 1997) .
FIG. 2. Detection of rotavirus VP7 expressed by vaccinia virus recombinants using Western blotting (A) and immunoprecipitation (B). For immunoblot analysis, 143TK
Ϫ cells were infected with vaccinia virus recombinants and MA104 cells were infected with SA11 rotavirus as a control. At 9 and 24 h postinfection proteins were extracted, subjected to electrophoresis on 10% SDS-PAGE, and electroblotted onto nitrocellulose. After the membrane was blocked with Tris-buffered saline containing 3% BSA, a hyperimmune goat anti-rotavirus serum was added and incubated overnight. The second antibody was an anti-goat IgG peroxidase conjugate and the substrate used was 3-amino-9-ethylcarbazole. For immunoprecipitation of VP7 expressed by the recombinant vaccinia viruses V V-VP7-RF and V V-VP7-SA11 and of a carboxy-terminally truncated VP7 molecule expressed by V V-VP7-5Ј, 143TK
Ϫ cells were infected with 20 m.o.i. of rV V and proteins labeled with [ 35 S]methionine:cysteine. At 12 h postinfection, cells were washed and lysed. The radiolabeled lysate from SA11-infected cells was incubated with a polyclonal human anti-rotavirus serum, whereas lysates from rV V-infected cells were incubated with an anti-VP7 MAb. Immune complexes were precipitated with protein A-Sepharose and analyzed by electrophoresis on a 10-20% gradient SDS-polyacrylamide gel. The gel was fixed, dried, and processed for fluorography as described (Colomina et al., 1998) .
Rotavirus-specific CTL are detected in mucosal nodes (Peyer's patches and mesenteric lymph nodes) early in infection and are later detected in the spleens of rotavirus-infected mice (Offit et al., 1991b) . It has been demonstrated that CD8 ϩ T cells play an important role in the resolution of rotavirus primary infection and a much lesser role in protection from reinfection (Rosé et al., 1998; Franco and Greenberg, 1995; Franco et al., 1997) .
ϩ ) in calves by administration of monoclonal antibodies demonstrated that CD8 ϩ cells are involved in restricting rotavirus growth and that CD4 ϩ T lymphocytes help the generation of mucosal and systemic rotavirus-specific antibodies (Oldham et al., 1993) . Furthermore, it was demonstrated recently that the expression of the mucosal homing receptor ␣ 4 ␤ 7 correlates with the ability of CD8 ϩ memory T cells to clear rotavirus infections (Rosé et al., 1998) .
In the present study, CTL were generated by inoculating suckling mice by the oral route to reproduce the disease in the experimental model such that viral antigens would be primarily processed and presented to T lymphocytes in the gut epithelium, as occurs during the course of natural rotavirus infections. It has been reported that rotavirus-specific CTL activity can be detected as early as 6 days after oral or parenteral inoculation of mice with rotavirus (Offit and Dudzik, 1989) . Preliminary experiments in our study showed that the levels of the CTL response were enhanced when mice infected neonatally with rotavirus were primed intraperitoneally with 10 7 PFU of the same virus strain 5 to 7 days before their spleens were removed (results not shown). The first goal of the present study was to determine whether splenocytes, derived from mice orally infected with different strains of rotavirus, mount a CTL response against target cells expressing VP7 from two different virus strains, the bovine RF strain (serotype G6) and the simian rotavirus SA11 (serotype G3). Our data confirm the existence of a cross-reactive CTL activity against VP7 of G3 and G6 specificities by effector cells generated with rotavirus strains Wa (G1), SA11 (G3), and EDIM (G3). This CTL response against VP7 has been found in several previous studies to be cross-reactive with respect to the virus G serotype (Offit et al., 1991a; 1993; Heath et al., 1997) but the cross-reactive T cell epitope (or epitopes) has not been characterized.
Lysis values of target cells infected with SA11 rotavirus were significantly greater (P Ͻ 0.001) than those detected against target cells infected with rVV expressing full-length VP7 (VV-VP7-SA11 and VV-VP7-RF). This observation could arise for several reasons: (i) a higher level of protein expression and presentation of the antigenic peptides in rotavirus-infected target cells compared to the rVV-VP7-infected cells; (ii) the generation of CTL responses to viral proteins other than VP7 since other target antigens of the rotavirus-specific cytotoxic T cell response have been identified in the inner capsid protein VP6 (Franco et al., 1994) , the core protein VP3 (Franco et al., 1994) , and the nonstructural protein NSP-1 (Heath et al., 1997) ; and (iii) differences in the induction of CTL, the activation of CTLp cells, and the CTL repertoire.
CTL responses manifested by H-2 d splenocytes against target cells infected with VV-VP7-5Ј were similar to those against targets infected with VV-VP7-SA11 or VV-VP7-RF. By contrast, lysis values of target cells infected with VV-VP7-5Ј by splenocytes derived from rotavirus-infected H-2 b mice were significantly lower (P Ͻ 0.001) than those detected against target cells infected with rVV expressing full-length VP7. This could be a consequence of the existence of additional CTL epitopes in other regions of the VP7 protein in the H-2 b background not expressed by the recombinant vaccinia virus VV-VP7-5Ј.
It has been suggested that signal peptides or fragments thereof may be presented by class I MHC antigens as T cell epitopes (Henderson et al., 1992) . A dominant target peptide presented by D b and recognized by cytotoxic T cells specific for lymphocytic choriomeningitis virus (LCMV) in H-2 b mice is derived from the signal sequence of the viral glycoprotein precursor GP-C (Buchmeier and Zinkernagel, 1992) .
Moreover, the immunogenicity of an immunorecessive CTL epitope present in the large T antigen of polyomavirus simian virus 40 (SV40) was significantly en- hanced by targeting it to the endoplasmic reticulum (ER) (Fu et al., 1998) .
During the rotavirus assembly process, the outer capsid VP7 glycoprotein becomes an integral membrane polypeptide of luminal orientation that probably contributes to the ability of this particular viral protein to elicit a CTL response. In fact, VP7 is an ER membrane-associated glycoprotein. The VP7 gene encodes 326 amino acids that have two tandem hydrophobic domains at the amino terminus, each preceded by an ATG codon (Poruchynsky et al., 1985) . Both hydrophobic sequences, H1 (residues 1-29) and H2 (residues 30-50), can function as signal peptides to direct the protein into the ER. The ER retention motif of VP7, which does not include KDEL or lysine residues, has been analyzed in many studies (Poruchynsky et al., 1985; Stirzaker et al., 1987 Stirzaker et al., , 1990 Clarke et al., 1995) . It has been demonstrated that 3 amino acids at the amino terminus, residues lle-9, Thr-10, and Gly-11, are essential amino acids of the VP7 ER retention signal (Maass and Atkinson, 1994) . Rotavirus is one of the few viruses that uses the ER for assembly and has therefore been an attractive model with which to study ER translocation, retention, and protein folding.
Of the peptides used in the present study to characterize CTL epitopes, three were clearly recognized by splenocytes from rotavirus-infected mice: Kb8-16 and Kb31-40, both presented in the context of H-2K b , and Kd5-13, which is H-2K d restricted. The sequence of peptide Kb31-40, which contains two potential K b -restricted motifs, was previously analyzed by Franco et al. (1993) in mice immunized with the RF strain of bovine rotavirus. They reported that the epitope located at the carboxyterminal motif of this peptide is an immunodominant cytotoxic T cell epitope of the VP7 rotavirus protein. The anchor positions for both potential epitopes are conserved among the amino acid sequences of rotavirus strains SA11, RF, Wa, and EDIM, as well as in the other FIG. 6 . Specific lysis of Kd5-13 peptide-sensitized target cells by peptide-stimulated splenocytes from BALB/c mice infected with either SA11 or EDIM rotavirus strains. P815 target cells were incubated for 2 h with different peptide concentrations before addition of effectors at an E:T cell ratio of 50:1. MC57 cells were used as targets to verify the MHC restriction of the effector population derived from SA11-infected BALB/c mice. b Target cells were labeled with 51 Cr and sensitized with peptides at a concentration of 10 Ϫ6 M for 2 h at 37°C, after which effector cells were added at an E:T ratio of 50:1. The cell mixtures were incubated for 5 h and 51 Cr released in the fluid phase was measured in a gamma counter. The specific 51 Cr release was calculated as described under Materials and Methods. Numbers shown represent mean values plus and minus the SEM. Cell lysis values at least twice the value of mock-infected or V V-sc11-infected target cells are shown in boldface type.
c ND, not determined.
rotavirus strains compared in Table 4 , making this epitope a good candidate for the cross-reactivity to VP7. It is interesting to note that the sequence of peptide Db48-57 (which encompasses a potential H-2D b -restricted epitope) is highly conserved in all the rotavirus strains analyzed, except for the first two amino acids. However, this peptide was not recognized in CTL assays. As was established by Oldstone et al. (1995) , the prediction of potential CTL epitopes based merely on primary sequence analysis and identification of MHC class I allele specific anchoring motifs is of limited value, and only a restricted number induce CTL activity.
CTL responses generated by splenocytes from SA11 and Wa-infected mice to target cells sensitized with peptide Kb8-16 (TVLTFLISI) were stronger than those detected against target cells sensitized with peptide Kb31-40. This intense CTL activity, with recognition and lysis of cells expressing peptide Kb8-16, was not detected with effector cells derived from EDIM-infected H-2 b mice. This can be explained by the differences occurring in the last anchor residue of the H-2K b -restricted motif, I-16 for F in the VP7 sequence of the EDIM strain, which occurs in mouse rotavirus strains (EW, EB) and in some human strains such as HCR3 and PV5249 (Table 4) . It is well known that single amino acid substitutions within a class I-restricted epitope can abrogate CTL recognition by eliminating the proteolytic cleavage site required for the generation of the antigenic peptide, by decreasing the binding affinity of the peptide for the MHC molecule, or by altering the peptide-MHC complex so that it is no longer recognized by the T cell receptor (Couillin et al., 1994; Ossendorp et al., 1996) . In addition, peptide Kd5-13 (EYTTVLTFL) was found to generate recognition and lysis by CTL from both SA11 and EDIM-infected BALB/c H-2 d mice. As observed in the screening experiments (Table 2) , the peptide dilution experiment (Fig. 6) confirmed the specific cytotoxicity against peptide Kd5-13-sensitized target cells. From our results, we conclude that both epitopes, whose sequences overlap and which are located within the H1 signal sequence of the VP7 glycoprotein, are recognized by splenocytes derived from rotavirus-infected mice. However, experiments designed to provide evidence that the synthetic peptides used in our study represent the optimal ones for each CTL response remain to be performed.
It has been shown that there is a hierarchy in the epitope specificity of MHC class I-restricted epitopes (van der Most et al., 1996) . CTL determinants can be dominant, subdominant, or even cryptic. It has been postulated that in vivo activation of subdominant epitopes can occur in some viral infections, that CTL directed against these epitopes are capable of controlNote. The sequences of the amino-terminal regions of 12 strains of animal and human rotaviruses are shown for comparison. The sequence of SA11 is that originally reported by Both et al. (1983) (GenBank Accession No. V01546) with two changes reported by Stirzaker et al. (1987) , C-32 to F and L-37 to F, which were confirmed by the sequencing of the SA11 strain used in this study. Peptides Kd5-13, Kb8-16, and Kb31-40 are enclosed in rectangles A, B, and C, respectively. Amino acid residues that are identical to that of SA11 are shown as dashes (-).
ling infection, and that previously subdominant epitopes can become dominant under different conditions van der Most et al., 1996) . The hierarchy among the CTL epitopes identified so far in VP7 needs to be determined.
The observation that CTL epitopes form clusters within viral proteins has recently been described in viruses infecting both humans and mice. The existence of overlapping epitopes has been reported in the influenza A virus nucleoprotein (Tussey et al., 1995) as well as in the human immunodeficiency virus type 1 gp120 presented by HLA A, B, and C molecules (Wilson et al., 1997) . Likewise, it has been found in H-2 b mice that the H-2 brestricted epitope contained in the signal sequence of lymphocytic choriomeningitis virus GP1 also harbors an H-2D b -restricted binding motif (Hudrisier et al., 1997) . Comparative analysis of the VP7 amino acid sequences of strains belonging to the G3 serotype has revealed similarities ranging from 88.7 to 99.4%, whereas among strains representing 13 G serotypes amino acid sequence similarities range from 60.4 to 88.3% (Li et al., 1994) . Although sequence divergence has been found to occur primarily in the VP7-serotype-specific regions, the amino-terminal region of VP7 is not as well conserved as the carboxy-terminal sequence (Kapikian and Chanock, 1996) . This favors the hypothesis that CTL epitopes can be variable among different strains and serotypes of rotavirus. However, it is interesting to know which epitopes mount CTL responses sufficient to clear virus and control infection. Such information will open the way to the development of DNA vaccines that might deliver multiple CTL epitopes to generate DC8 ϩ CTL responses (Chen et al., 1998) .
MATERIALS AND METHODS
Mice
Four-to six-week-old BALB/c (H-2 d ) and C57BL/6 (H-2 b ) mice were purchased from IFFA Credo (Barcelona, Spain). The animals were periodically tested for the absence of anti-rotavirus antibody by ELISA. Uninfected mice remained seronegative during the study. They were reared separately from the rotavirus-infected animals, which were kept in different animal facilities. All procedures were conducted in accordance with the regulations established by the European Community Council on the protection of animals with experimental and scientific applications (86/609/CEE).
Cell lines
MA104 cells were grown in Eagle's minimum essential medium supplemented with 10% heat-inactivated fetal bovine serum (FBS) (Gibco BRL, Paisley, UK), 2 mM L-glutamine, 100 g/ml streptomycin sulfate, and 100 units/ml penicillin. CV-1 cells were grown in Dulbecco's modified Eagle's medium (Gibco BRL) containing 10% FBS. Plastic-adherent 143TK
, and Balb Cl.7 (H-2 d ) cells were generously provided by J. L. Whitton (The Scripps Research Institute, La Jolla, CA) and grown as described (Whitton et al., 1988a (G3, P10 [16] ), originally obtained from R. Ward (Children's Hospital Research Foundation, Cinncinati, OH), were grown in MA104 cells in the presence of 1 g/ml trypsin (type IX, Sigma Chemical Co., St. Louis, MO) as previously described (Sato et al., 1981) . The titers of the SA11 and Wa viral stocks were determined by plaque assay as described (Urasawa et al., 1982) and EDIM virus preparations were quantified by a fluorescence focus assay described elsewhere (Bernstein et al., 1987) .
Vaccinia virus (WR strain) (American Type Culture Collection) was used to generate recombinant viruses. A vaccinia virus recombinant with gene 9 of bovine rotavirus strain RF (serotype G6) was kindly provided by J. Cohen (INRA, Jouy-en-Josas, France). Vaccinia viruses were propagated on CV-1 cells as described (Chakrabarti et al., 1985) .
Purification of viral RNA and synthesis of cDNA MA104 cells were infected with 1 m.o.i. of the SA11 rotavirus previously activated with 10 g/ml of trypsin. When a 90% cytopathic effect was achieved, cell cultures were freeze-thawed three times and fluorocarbon extracted as described (Offit et al., 1983) . Viral RNA was obtained from the crude virus preparation by phenolchloroform extraction and ethanol precipitation. Reverse transcription-polymerase chain reaction (RT-PCR) was applied to generate and amplify cDNA of rotavirus gene 9 as previously described (Buesa et al., 1996) . The primers used have been described by Gouvea et al. (1990) and are specific for the gene coding for VP7, which may be RNA segment 7, 8, or 9 depending on the viral strain, and produce full-length copies of the gene from any group A rotavirus strain.
Cloning of the VP7 gene in pSC11 vector
Following standard cloning procedures (Ausubel et al., 1996) the VP7 cDNA of SA11 rotavirus was cloned into the SmaI site of the transfer plasmid pSC11 (Chakrabarti et al., 1985) . Ligation products were transformed into E. coli strain DH5␣ and colonies containing recombinant plasmids were selected by PCR using primers described by Sheng et al. (1993) .
Construction of a gene 9 5Ј fragment that codes for a carboxy-terminally truncated VP7 protein
The following 5Ј and 3Ј primers were designed to amplify a cDNA fragment from SA11 rotavirus gene 9 encoding amino acids 1 to 88 of VP7, with the inclusion of the restriction sites EcoRI and BamHI, respectively, in order to allow the cloning of this fragment in the pUTT 2 vector: 5Ј-GGC TTT AAA AGA GAG AAT TCC CGT TTG G (nucleotides 1-28, EcoRI sequence underlined) and 5Ј-TTC AGT CGG ATC CTC AGT CGG AT (complementary to nucleotides 302-324, BamHI sequence underlined). The pUTT 2 plasmid encodes a translational termination codon in each of the three reading frames downstream of a multiple cloning site (Whitton et al., 1988b) . The 5Ј fragment of rotavirus gene 9 was excised from pUTT 2 by EcoRI and HindIII digestion, termini were made blunt with Klenow enzyme, and the fragment was cloned into the SmaI site of the pSC11 vector. The nucleotide sequence of the insert was determined using the T7 RNA Sequence System (Amersham Pharmacia Biotech, Rainham, UK).
Construction of recombinant vaccinia viruses
Recombinant vaccinia viruses were produced essentially as described by Earl and Moss (1993) . Briefly, CV-1 cells infected with vaccinia virus were transfected with 100 ng of calcium phosphate-precipitated recombinant plasmid pSC11-VP7. Thymidine kinase selection and screening of recombinant virus plaques were carried out on 143TK
Ϫ cells grown in minimum essential medium containing 2.5% FBS and 25 g/ml 5-bromodeoxyuridine. For plaque assays involving the isolation of recombinant viruses, 200 g/ml of XGal (Promega, Madison, WI) was added in the agarose overlay. For use as negative control, a vaccinia virus recombinant carrying the lacZ gene from the transfer plasmid pSC11 (VV-sc11) was constructed. Three cycles of plaque purification were carried out before recombinant plaque isolates were amplified for use in CTL assays.
Analysis of recombinant viruses by PCR, Southern blot hybridization, and nucleotide sequencing
The DNA sequences of fragments inserted into vaccinia virus were determined by performing PCR with the primers described by Sheng et al. (1993) and sequencing the PCR products. Southern blot analysis was performed as described with DNA extracted from recombinant vaccinia viruses, digested with HindIII, blotted onto a nylon membrane (GeneScreen, DuPont NEN, Dreieich, Germany), and hybridized with a 32 P-labeled rotavirus cDNA gene 9 probe (Ausubel et al., 1996) .
Detection of VP7 expression by immunofluorescence, Western blotting, and radioimmunoprecipitation (RIPA)
Polypeptides synthesized by recombinant vaccinia viruses were analyzed by indirect immunofluorescence. Monolayers of CV-1 cells that had been grown to semiconfluency on round glass coverslips were infected with recombinant or control vaccinia viruses. At 9 to 16 h postinfection cells were fixed with 3% paraformaldehyde in PBS for 30 min at room temperature. The coverslips were then treated with 1% Triton X-100 to permeabilize the cells. After two rinses in PBS, the cells were incubated for 45 min at 37°C with either hyperimmune antirotavirus serum bovine (Wellcome Diagnostics, Dartford, UK) diluted 1:80 in PBS containing 1% bovine serum albumin (PBS-BSA) or a mixture of three MAbs against VP7 (3C3, 5A10, and 4C3) (Gerna et al., 1988) KCl, 5 mM EDTA, 2% Triton X-100, 1 mM PMSF, and 1 g/ml aprotinin]. Thirty microliters of radiolabeled lysate was incubated with either 5 l of polyclonal human anti-rotavirus serum or 2 l of ascitic fluid with MAb 4C3 directed against VP7. Immune complexes were precipitated with protein A-Sepharose CL-4B (Sigma), washed three times with RIPA buffer [50 mM Tris ⅐ HCl (pH 7.4), 150 mM NaCl, 1 mM EDTA, 0.25% BSA, 0.05% Triton X-100, 0.02% N 3 Na], and subjected to SDS-PAGE on a 10-20% gradient gel. The gel was fixed, dried, soaked in Amplify (Amersham Pharmacia Biotech), and autoradiographed as previously described (Colomina et al., 1998) .
Synthetic peptides
Peptides were designed to characterize T cell epitopes in the amino-terminal region of the SA11 VP7 molecule according to the sequence motifs described by Falk et al. (1991) for predicting CTL epitopes presented by class I MHC molecules. These peptides were purchased from Genosys Biotechnologies, Inc. (Cambridge, UK) and from Neosystem Laboratoire (Strasbourg, France). Their sequences, H-2 motifs, and the mouse strains used to generate CTL responses to them are shown in Table 1 . Peptide Kb31-40 was originally described by Franco et al. (1993) and contains two overlapping K b motifs. This peptide, covering amino acids 31-40 of VP7 from the RF strain of bovine rotavirus, was also tested in this study, although the sequence was modified at two residues (Y-32 to F and L-39 to F) to be adapted to the amino acid sequence of VP7 from SA11.
Peptides were diluted in PBS containing 1% BSA and 10% DMSO to yield stock solutions of 10 Ϫ3 M and were stored at Ϫ20°C.
Immunization of mice
Litters of suckling BALB/c and C57BL/6 mice (6-9 days old) were orally inoculated with SA11 (125 mice), Wa (158 mice), or EDIM (99 mice) rotavirus strains. The viral doses orally given to mice were of 5 ϫ 10 6 PFU for SA11 and Wa strains and of 6 ϫ 10 4 FFU for the EDIM strain. Inoculated animals were housed in separate isolation units and were examined daily for diarrhea by gentle palpation of the abdomen. Mock-infected animals received an equal volume of culture medium from uninfected MA104 cells. At 6-8 weeks of age, mice were primed intraperitoneally with the neonatally administered viral strain, either homologous (10 5 FFU of the EDIM strain) or heterologous rotaviruses (10 7 PFU of either SA11 or Wa strains).
CTL generation
To determine the CTL response, immunized mice were sacrificed by vertebral dislocation 5 to 7 days after the last virus challenge and their spleens were removed aseptically. Single-cell suspensions were prepared by careful dissection with needles and filtering the tissue fragments through a 100-mesh sieve in a tissue grinder (Sigma). Erythrocytes were lysed in 0.85% NH 4 Cl in PBS prewarmed to 37°C and lymphocytes were washed twice in RPMI medium and finally suspended in complete medium: RPMI 1640 containing 10% FBS, 20 mM HEPES, 30 M 2-mercaptoethanol, 2.5 mM sodium pyruvate, 100 g/ml streptomycin, and 100 U/ml penicillin. Stimulator cells were splenocytes obtained from nonimmune syngeneic mice, incubated with 1 m.o.i. of rotavirus for 1 h, and treated afterward for 20 min with 25 g/ml mitomycin C (Boehringer Mannheim, Mannheim, Germany). These cells were washed three times and mixed with the effector cell population in a 1:2 ratio. Cell mixtures were adjusted to 5 ϫ 10 6 cells/ml in RPMI complete medium, distributed in 24-well plates, and incubated for 5 days at 37°C to allow stimulation and expansion of virus-specific CTL precursor cells (CTLp). For stimulation with peptides, splenocytes were incubated with each peptide at 10 Ϫ4 M for 5 days at 37°C.
Cytotoxicity assay
A standard 51 Cr release assay (Whitton et al., 1988a; Offit and Dudzik, 1988; Franco et al., 1993) was used to measure CTL activity. For use as target cells, MC57, Balb Cl.7, or P815 cells were infected with 2-5 m.o.i. of vaccinia virus recombinants or with 100-130 m.o.i. of rotavirus SA11. After a 5-h incubation at 37°C, the cells were trypsinized, washed, counted, centrifuged, and labeled for 1 h at 37°C with 50-100 Ci of 51 Cr (Amersham Pharmacia Biotech). Cells were then washed three times and distributed in 96-well plates at 10,000 cells/well. For CTL assays performed with peptides, target cells were labeled with 51 Cr and distributed in 96-well plates as above and then incubated for 2 h at 37°C with peptides at 10 Ϫ6 M. Serial dilutions of peptides from 10 Ϫ5 to 10 Ϫ12 M were used to sensitize target cells when the screening experiment showed significant lysis values. Effector cells were added at the appropriate concentrations to obtain various effector:target (E:T) cell ratios (12.5:1, 25:1, and 50:1) in a total volume of 200 l. In CTL assays performed with peptides, the E:T cell ratio used was 50:1. Spontaneous and total releases of 51 Cr were calculated by incubating target cells in each experiment with medium only and with 10% Triton X-100, respectively. After a 5-h incubation at 37°C the plates were centrifuged at 500 g for 5 min and 100 l of supernatant was removed from each well and counted in a gamma counter (SpectraGamma, Packard Instruments Co., Meriden, CT). The percentage of specific lysis was calculated as 100 ϫ [(cpm released by CTL Ϫ cpm of spontaneous release)/(cpm of total release Ϫ cpm of spontaneous release)]. A response was considered positive when it was at least double the lysis value of control target cells (mock-infected and/or VV-sc11-infected cells). The results were obtained from two or three experiments and each experiment was performed in triplicate. Results are expressed as mean values plus and minus the standard error of the mean (SEM).
Statistical analysis
Analysis of variance was carried out on the percentage lysis values to test for significant differences between different experimental groups. The two-tailed Student t test was used to compare the differences between individual group means. Significance, when applied in a statistical comparison, implies a P value of Ͻ0.001.
